RETINALGENIX TECHNOLOGIES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 0.00 shares.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 0.00 shares.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-06-30 was 20.00K shares.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 150.00K shares.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 170.00K shares.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 25.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 170.00K shares 10-K · filed 2026-04-15 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | |
| 2024-06-30 | 20.00K shares 10-Q · filed 2025-11-14 | |
| 2024-03-31 | 150.00K shares 10-Q · filed 2025-11-14 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 25.00K shares 10-K · filed 2024-04-01 |